154 related articles for article (PubMed ID: 18424236)
1. Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways.
Yu QT; Saruta M; Papadakis KA
Clin Immunol; 2008 Jun; 127(3):322-9. PubMed ID: 18424236
[TBL] [Abstract][Full Text] [Related]
2. A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis.
Plevy S; Salzberg B; Van Assche G; Regueiro M; Hommes D; Sandborn W; Hanauer S; Targan S; Mayer L; Mahadevan U; Frankel M; Lowder J
Gastroenterology; 2007 Nov; 133(5):1414-22. PubMed ID: 17920064
[TBL] [Abstract][Full Text] [Related]
3. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
[TBL] [Abstract][Full Text] [Related]
4. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
[TBL] [Abstract][Full Text] [Related]
5. Contribution of TIA-1+ and granzyme B+ cytotoxic T lymphocytes to cryptal apoptosis and ulceration in active inflammatory bowel disease.
Mitomi H; Ohkura Y; Yokoyama K; Sada M; Kobayashi K; Tanabe S; Fukui N; Kanazawa H; Kishimoto I; Saigenji K
Pathol Res Pract; 2007; 203(10):717-23. PubMed ID: 17869012
[TBL] [Abstract][Full Text] [Related]
6. Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis.
Boirivant M; Pica R; DeMaria R; Testi R; Pallone F; Strober W
J Clin Invest; 1996 Dec; 98(11):2616-22. PubMed ID: 8958226
[TBL] [Abstract][Full Text] [Related]
7. Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease.
Doering J; Begue B; Lentze MJ; Rieux-Laucat F; Goulet O; Schmitz J; Cerf-Bensussan N; Ruemmele FM
Gut; 2004 Nov; 53(11):1632-8. PubMed ID: 15479684
[TBL] [Abstract][Full Text] [Related]
8. CD44v7 ligation downregulates the inflammatory immune response in Crohn's disease patients by apoptosis induction in mononuclear cells from the lamina propria.
Hoffmann U; Heilmann K; Hayford C; Stallmach A; Wahnschaffe U; Zeitz M; Günthert U; Wittig BM
Cell Death Differ; 2007 Aug; 14(8):1542-51. PubMed ID: 17479111
[TBL] [Abstract][Full Text] [Related]
9. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes.
Malviya G; D'Alessandria C; Bonanno E; Vexler V; Massari R; Trotta C; Scopinaro F; Dierckx R; Signore A
J Nucl Med; 2009 Oct; 50(10):1683-91. PubMed ID: 19759100
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation.
Caprioli F; Stolfi C; Caruso R; Fina D; Sica G; Biancone L; Pallone F; Monteleone G
Gut; 2008 Dec; 57(12):1674-80. PubMed ID: 18625693
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to Fas and tumor necrosis factor-alpha receptor mediated apoptosis of anti-CD3/anti-CD28-activated umbilical cord blood T cells.
Lin SJ; Lee CC; Cheng PJ; See LC; Kuo ML
Pediatr Allergy Immunol; 2009 Jun; 20(4):392-8. PubMed ID: 18713315
[TBL] [Abstract][Full Text] [Related]
12. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and functional analysis of lamina propria mononuclear cells from colonoscopic biopsy specimens in patients with ulcerative colitis.
Haruta J; Kusugami K; Kuroiwa A; Ina K; Shinoda M; Morise K; Iokawa H; Morita M; Ishihara A; Sarai S
Am J Gastroenterol; 1992 Apr; 87(4):448-54. PubMed ID: 1553932
[TBL] [Abstract][Full Text] [Related]
14. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.
D'Ambrosio A; Cossu A; Amendola A; Zandri A; Butera A; Sanchez M; Biffoni M; Pronio A; Montesani C; Kohn A; Pica R; Boirivant M
J Crohns Colitis; 2016 Mar; 10(3):346-53. PubMed ID: 26589955
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis resistance in ulcerative colitis: high expression of decoy receptors by lamina propria T cells.
Fayad R; Brand MI; Stone D; Keshavarzian A; Qiao L
Eur J Immunol; 2006 Aug; 36(8):2215-22. PubMed ID: 16856205
[TBL] [Abstract][Full Text] [Related]
17. A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis.
Monteleone I; Monteleone G; Fina D; Caruso R; Petruzziello C; Calabrese E; Biancone L; Pallone F
Gastroenterology; 2006 Feb; 130(2):389-97. PubMed ID: 16472594
[TBL] [Abstract][Full Text] [Related]
18. [Functional status of intestinal t lymphocytes, regulatory mechanisms, and their variations in the course of Crohn disease and ulcerative colitis].
Boirivant M; Marini M; Di Felice G
Ann Ist Super Sanita; 1999; 35(2):283-9. PubMed ID: 10645662
[TBL] [Abstract][Full Text] [Related]
19. Characterization of immunoregulatory T cells and lymphocytophilic antibodies in ulcerative colitis: analysis with monoclonal antibodies.
Aiso S; Watanabe M; Hibi T; Yoshida T; Tsuchiya M; Tsuru S
J Clin Lab Immunol; 1982 Nov; 9(2):109-12. PubMed ID: 6984077
[TBL] [Abstract][Full Text] [Related]
20. Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy.
Sumida Y; Nakamura K; Kanayama K; Akiho H; Teshima T; Takayanagi R
Cytotherapy; 2008; 10(7):698-710. PubMed ID: 18985477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
